Template:Neuroendocrine tumors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 10: | Line 10: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# | [[Neuroendocrine tumors# Patient Information|Patient Information]] | ||
|- | |- | ||
! | ! | ||
| Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors # | [[Neuroendocrine tumors #Overview|Overview]] | ||
|- | |- | ||
! | ! | ||
| Line 22: | Line 22: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# Historical Perspective|Historical Perspective]] | [[Neuroendocrine tumors#Historical Perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
| Line 28: | Line 28: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# Classification|Classification]] | [[Neuroendocrine tumors#Classification|Classification]] | ||
|- | |- | ||
! | ! | ||
| Line 34: | Line 34: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# Pathophysiology|Pathophysiology]] | [[Neuroendocrine tumors#Pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
| Line 40: | Line 40: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# Causes|Causes]] | [[Neuroendocrine tumors#Causes|Causes]] | ||
|- | |- | ||
! | ! | ||
| Line 46: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# Epidemiology and Demographics|Epidemiology and Demographics]] | [[Neuroendocrine tumors#Epidemiology and Demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# Risk factors|Risk factors]] | [[Neuroendocrine tumors#Risk factors|Risk factors]] | ||
|- | |- | ||
! | ! | ||
| Line 57: | Line 57: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# | [[Neuroendocrine tumors#Natural History, Complications and Prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
| Line 63: | Line 63: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# History and Symptoms|History and Symptoms]] | [[Neuroendocrine tumors#History and Symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
| Line 69: | Line 69: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# Laboratory Findings|Laboratory Findings]] | [[Neuroendocrine tumors#Laboratory Findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
| Line 75: | Line 75: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# CT scan|CT scan]] | [[Neuroendocrine tumors#CT scan|CT scan]] | ||
|- | |- | ||
! | ! | ||
| Line 81: | Line 81: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# PET scan|PET scan]] | [[Neuroendocrine tumors#PET scan|PET scan]] | ||
|- | |- | ||
! | ! | ||
| Line 87: | Line 87: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# Medical Therapy|Medical Therapy]] | [[Neuroendocrine tumors#Medical Therapy|Medical Therapy]] | ||
|- | |- | ||
! | ! | ||
| Line 93: | Line 93: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# Surgery|Surgery]] | [[Neuroendocrine tumors#Surgery|Surgery]] | ||
|- | |- | ||
! | ! | ||
Latest revision as of 07:44, 13 November 2019
|
Neuroendocrine tumors Microchapters |
<templatedata> { "params": {} } </templatedata>